HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination.

AbstractBACKGROUND:
High-density lipoprotein (HDL) functionality and low-density lipoprotein (LDL) atherogenic traits can describe the role of both particles on cardiovascular diseases more accurately than HDL- or LDL-cholesterol levels. However, it is unclear how these lipoprotein properties are particularly affected by different cardiovascular risk factors.
OBJECTIVE:
To determine which lipoprotein properties are associated with greater cardiovascular risk scores and each cardiovascular risk factor.
METHODS:
In two cross-sectional baseline samples of PREDIMED trial volunteers, we assessed the associations of HDL functionality (N = 296) and LDL atherogenicity traits (N = 210) with: 1) the 10-year predicted coronary risk (according to the Framingham-REGICOR score), and 2) classical cardiovascular risk factors.
RESULTS:
Greater cardiovascular risk scores were associated with low cholesterol efflux values; oxidized, triglyceride-rich, small HDL particles; and small LDLs with low resistance against oxidation (P-trend<0.05, all). After adjusting for the rest of risk factors; 1) type-2 diabetic individuals presented smaller and more oxidized LDLs (P<0.026, all); 2) dyslipidemic participants had smaller HDLs with an impaired capacity to metabolize cholesterol (P<0.035, all); 3) high body mass index values were associated to lower HDL and LDL size and a lower HDL capacity to esterify cholesterol (P<0.037, all); 4) men presented a greater HDL oxidation and lower HDL vasodilatory capacity (P<0.046, all); and 5) greater ages were related to small, oxidized, cytotoxic LDL particles (P<0.037, all).
CONCLUSIONS:
Dysfunctional HDL and atherogenic LDL particles are present in high cardiovascular risk patients. Dyslipidemia and male sex are predominantly linked to HDL dysfunctionality, whilst diabetes and advanced age are associated with LDL atherogenicity.
AuthorsÁlvaro Hernáez, María Trinidad Soria-Florido, Helmut Schröder, Emilio Ros, Xavier Pintó, Ramón Estruch, Jordi Salas-Salvadó, Dolores Corella, Fernando Arós, Lluis Serra-Majem, Miguel Ángel Martínez-González, Miquel Fiol, José Lapetra, Roberto Elosua, Rosa María Lamuela-Raventós, Montserrat Fitó
JournalPloS one (PLoS One) Vol. 14 Issue 6 Pg. e0218533 ( 2019) ISSN: 1932-6203 [Electronic] United States
PMID31246976 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Lipoproteins, HDL
  • Lipoproteins, LDL
Topics
  • Adult
  • Age Factors
  • Aged
  • Atherosclerosis (blood, complications)
  • Cardiovascular Diseases (blood, etiology)
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 (blood, complications)
  • Dyslipidemias (blood, complications)
  • Female
  • Humans
  • Lipoproteins, HDL (blood)
  • Lipoproteins, LDL (blood)
  • Male
  • Middle Aged
  • Risk Factors
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: